多b值DWI在脑胶质瘤治疗后近期评价中的应用
本文关键词: 胶质瘤 治疗 扩散磁共振成像 表观扩散系数 肿瘤进展 出处:《中国医学影像技术》2017年08期 论文类型:期刊论文
【摘要】:目的探讨应用多b值DWI中不同b值ADC值评估胶质瘤近期治疗效果及鉴别肿瘤进展的价值。方法对47例经手术病理证实为脑胶质瘤且接受联合放化疗的患者行常规MRI及多b值DWI(b=0、1 000、2 000、3 000s/mm~2)扫描。分别在5种不同b值组合(b值组合分别为:0、1 000s/mm~2,0、2 000s/mm~2,0、3 000s/mm~2,1 000、3 000s/mm~2,2 000、3 000s/mm~2)的ADC图[ADC_((1 000/0))、ADC_((/2 000/0))、ADC_((3 000/0))、ADC_((3 000/1 000))、ADC_((3 000/2 000))]中测量病灶的平均和最小ADC值(ADC_(mean)和ADCmin),计算其相对值(rADC_(mean)、rADCmin)。比较治疗后不同反应类型(完全有效、部分有效、稳定、进展)间及进展组与非进展组间ADC值的差异,通过ROC曲线分析不同ADC值诊断肿瘤进展的最佳临界值和诊断效能。结果 ADC_((3 000/0))、ADC_((3 000/1 000))和ADC_((3 000/2 000))图中的rADC_(mean)在不同反应类型间和进展组与非进展组间差异均有统计学意义(P均0.05);ADC_((3 000/1 000))和ADC_((3 000/2 000))图中的ADC_(mean)在不同反应类型间和进展组与非进展组间差异均有统计学意义(P均0.05)。ADC_((3 000/2 000))图中ADC_(mean)和rADC_(mean)诊断肿瘤进展的曲线下面积最大,分别为0.86和0.84,以ADC_(mean)=408.65×10~(-6)mm~2/s和rADC_(mean)=1.12诊断胶质瘤进展的敏感度、特异度分别为89.3%、71.0%和92.9%、77.4%。结论通过高b值ADC图中病灶的ADC_(mean)和rADC_(mean)可较准确地评估胶质瘤的近期治疗效果,并为鉴别胶质瘤术后肿瘤进展提供有价值的信息。
[Abstract]:Objective to evaluate the value of different b value ADC values of multiple b DWI in evaluating the short-term therapeutic effect of gliomas and differentiating the progression of gliomas. Methods 47 patients with gliomas confirmed by surgery and pathology who received combined radiotherapy and chemotherapy were treated with routine procedure. MRI and multi-b DWIBU / 2000 / 2000 / 3 000s / mm-2) scanning. The average and minimum ADC values of ADC were measured in 5 different combinations of b values of 0 1 000 s / r / mm / 2 0 000 s / r / m / 2 000 s / r / r / t / 2 000 s / r / m / 2000s / r / r 2000sr / mm / 2000sr / r / r 2000s / r / m ~ 2000s / r / r ADC_((1 / 2000 / P / P / P / P / P / P / P / P / P of ADCA / ADCD / P / P / P / P / P / 0 / 0 / 0 respectively.] average and minimum ADC values were calculated for the mean and minimum ADC values of DCQ / ADCP / ADCP / ADCP / ADCP / 0 / 0 / 0 / 0 / 0 / 0 / 0 / 0 / 0 / 0 / 5 respectively.] the mean and minimum ADC values of the lesions were measured and the mean and minimum ADC values were calculated. The mean value of rADCM was compared with that of different types of response after treatment. The difference of ADC values between the partially effective, stable and progressive groups and between the progressive group and the non-progressive group, ROC curves were used to analyze the best critical value and diagnostic efficacy of different ADC values for diagnosis of tumor progression. Results there were significant differences in the rADCC mean between different reaction types and between progressive and non-progressive groups in the ADC_((3 000 / 0 0 / 0 ADC_((3 / D 0 / 0 0 / 0 / 10 ~ (000) and ADC_((3 000/2 ~ 000N) charts. There were significant differences between the two groups in terms of ADCS and ADC_((3 000/2 000). There were significant differences between the different reaction types and between the progressive group and the non progressive group. There was the largest area under the curve of ADCS mean and rADCmean) in the map of ADCS mean) and rADCmean for the diagnosis of the progression of the tumor, and the difference between the two groups was statistically significant (P = 0.05 and 0.05 respectively) and the area under the curve of the RAD mean was the largest in the map of ADCS and ADC_((3 000/2 000 (P = 0.05) and the difference between the progressive group and the non-progressive group was significant. The sensitivity of ADC_(mean)=408.65 脳 10 ~ (-6) / 2 / s and rADC_(mean)=1.12 in the diagnosis of glioma progression was 89.3% and 92.9%, respectively. Conclusion the short-term therapeutic effect of glioma can be evaluated more accurately by means of the ADCS mean and rADCV mean of the lesions on the high b value ADC map, and the sensitivity of the two methods is 89. 3% and 92. 9% respectively. It also provides valuable information for differentiating tumor progression after glioma operation.
【作者单位】: 河北医科大学第二医院影像科;黄骅市人民医院影像科;
【分类号】:R445.2;R739.41
【相似文献】
相关期刊论文 前10条
1 陈忠平,周旺宁;我国胶质瘤诊断治疗现状和努力方向[J];中国肿瘤;2005年02期
2 张纪;深入开展胶质瘤综合治疗及其基础研究[J];中华神经外科杂志;2003年01期
3 高广忠,王中,周幽心,周岱;手术治疗胶质瘤321例临床分析[J];苏州大学学报(医学版);2003年06期
4 邵忠,周幽心,姜华,张世明;手术治疗369例胶质瘤的临床分析[J];江苏大学学报(医学版);2004年06期
5 陈忠平;;从分子水平认识和治疗胶质瘤[J];中国肿瘤;2006年03期
6 仇德利;;胶质瘤治疗的现状与展望[J];医学理论与实践;2007年03期
7 吴登科;黄红星;;骨髓间充质干细胞用于胶质瘤治疗的相关研究进展[J];中华临床医师杂志(电子版);2008年03期
8 崔群建;周叶;杨柳三;;胶质瘤的综合治疗[J];医学信息;2008年08期
9 宋建国;严振平;邹志桓;温伟聪;扬小燕;曹林杰;王煜闲;;脑胶质细胞瘤微创治疗加化疗5例分析[J];中外医疗;2010年18期
10 曹培超;王建交;郑永日;;骨髓间充质干细胞在胶质瘤治疗中的作用[J];中国组织工程研究;2012年01期
相关会议论文 前10条
1 陈忠平;;胶质瘤规范化综合治疗的理解[A];中华医学会神经外科学分会第九次学术会议论文汇编[C];2010年
2 陈忠平M.D.Ph.D;;胶质瘤诊断治疗现状和努力方向[A];第三届中国肿瘤学术大会教育论文集[C];2004年
3 陈忠平;;胶质瘤耐药分子基础与临床应用[A];中国医师协会神经外科医师分会第二届全国代表大会论文汇编[C];2007年
4 陈忠平;;重视胶质瘤的规范化综合治疗[A];中国医师协会神经外科医师分会第二届全国代表大会论文汇编[C];2007年
5 田道锋;蔡强;张申起;吴立权;陈谦学;;胼胝体前部胶质瘤的显微手术治疗[A];湖北省抗癌协会青年委员会第五届青年学术论坛资料汇编[C];2013年
6 王连聪;;胶质瘤的放射治疗进展[A];2009年浙江省放射肿瘤治疗学学术年会论文汇编[C];2009年
7 王斌;卞修武;平轶芳;姜建勇;赵林涛;余世沧;王U,
本文编号:1542861
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/1542861.html